Recent News

• 05.28.2026 - Pelthos Therapeutics to Participate in 2026 Jefferies Global Healthcare Conference
• 05.14.2026 - Pelthos Therapeutics Announces First Quarter 2026 Financial Results
• 05.01.2026 - Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
• 04.14.2026 - Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
• 04.10.2026 - Pelthos Therapeutics Announces CFO Transition
• 03.31.2026 - Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
• 03.19.2026 - Pelthos Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results
• 03.12.2026 - Pelthos Therapeutics to Present at 38th Annual ROTH Conference
• 03.09.2026 - Pelthos Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
• 02.23.2026 - Pelthos Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Recent Filings